Lluís Montoliu: “This pandemic has helped us understand what the scientific method is all about.”
In conjunction with World Health Day, we are offering an interview with Lluís Montoliu, biologist and researcher at CSIC (Spanish National Research Council) in the National Biotechnology Center. The interview was held during The Pulse of Change: The Pulse of Change: Insights into the future of Health, an event held in Barcelona at Torre MAPFRE in collaboration with Accenture.
During the conversation, the expert geneticist shared his reflections on the genome, technology, and personalized precision medicine; revolutions such as cancer immunotherapy; advances in CRISPR tools; his research on rare diseases, genetics, and education; major achievements observed during the COVID-19 pandemic; deontology and ethical limits; and more.
Montoliu holds a bachelor’s degree and PhD in Biology from the University of Barcelona and has been a researcher at CSIC for more than 25 years, as well as at CIBERER (Rare Diseases Biomedical Research Network) of the Spanish National Biotechnology Center. He researches rare diseases such as albinism, using animal models genetically modified with CRISPR, which he pioneered in Spain.
Lluís Montoliu: “It is essential that we, as researchers, are not only dedicated to increasing knowledge and developing therapies, but also to telling the story behind it all.”
He has been a member and chairman of the CSIC Ethics Committee and is currently an advisor to the CSIC presidency on ethics matters and to Science Europe. He has received numerous awards for his research and is widely published. He has just published a book on pigmentation genes entitled Genes de colores [Genes of Colors] (Spanish version).